Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Value Fund” ...

Merck Group, the German pharmaceutical company, saw its Frankfurt-listed shares fall 10% on Tuesday morning after the company said it had decided to call off a Phase III trial of its cancer drug ...

Bulletin: ...WIND ADVISORY NOW IN EFFECT UNTIL 2 PM EDT THIS AFTERNOON... * WHAT...West winds 15 to 25 mph with gusts up to 50 mph. * WHERE...A portion of central ...

HUB internationally recognized pioneer in organoid development Acquisition expands Merck’s 2D and 3D cell culture portfolio Organoids part of fastest growing cell culture segment; hold potential to ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

The pharmaceutical giant is finding ways to navigate despite headwinds. This has helped the shares outperform the market over the past year. Income investors should be pleased with Merck's dividend ...

Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) Merck (NYSE: MRK), known ...

Belén Garijo, Chair of the Executive Board and CEO of Germany's Merck Group, stated in an interview with Xinhua News Agency on the 5th that Merck Group has always placed great importance on the ...

・As per Reuters, both the drugs have multibillion-dollar potential. ・FDA expects Merck to submit its applications for Enlicitide in April and for Sac-TMT in October or November next year. ・Other drugs ...

Managing Director of the Merck Group in Taiwan, John Lee, said that while Apple's decision to halt its MicroLED development is significant, it might open more doors for MicroLED manufacturers in ...